Multiple financial firms such as
Bleakley Financial Group,
M&G Plc, and
Sei Investments Co. have recently initiated or increased their investment in
Illumina, expressing confidence in the company’s prospects. This comes amidst several strategic changes within the firm. Notably,
Illumina’s Board approved the
spin-off of GRAIL and recently welcomed new Chief Office bearers -
Everett Cunningham as Chief Commercial Officer,
Ankur Dhingra as CFO, and
Jakob Wedel as Chief Strategy and Corporate Development Officer. The company's performance, however, has been a mixed bag, with the Q1 earnings beating market expectations but adjusted operating losses widening. Illumina, nonetheless, continues to show promise in the multiomics field with its latest acquisition of
Fluent BioSciences which aims to accelerate single-cell analysis and discovery. In another advancement, the company's move in NGS is noteworthy with the
DRAGEN v4.3 Launch.
Illumina ILMN News Analytics from Wed, 01 Nov 2023 07:00:00 GMT to Sun, 21 Jul 2024 14:46:18 GMT -
Rating 7
- Innovation 8
- Information 9
- Rumor -4
